(Q24300640)

Gene Ontology release 2020-05-02

Gene Ontology ID

GO:0070970

Purine nucleoside phosphorylase

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

author name string

Ana Toro

1

0 references

Melissa Paiva

2

0 references

Cameron Ackerley

3

0 references

Eyal Grunebaum

Reduced thymic output, increased spontaneous apoptosis and oligoclonal B cells in polyethylene glycol-adenosine deaminase-treated patients

4

0 references

language of work or name

English

0 references

publication date

April 2006

0 references

published in

Cellular Immunology

0 references

volume

240

0 references

page(s)

107-15

0 references

issue

2

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELLIMM.2006.07.003

7 January 2021

Mechanisms of apoptosis induced by purine nucleosides in astrocytes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELLIMM.2006.07.003

7 January 2021

TAT-mediated protein transduction into mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELLIMM.2006.07.003

7 January 2021

Adenosine deaminase and purine nucleoside phosphorylase deficiencies: evaluation of therapeutic interventions in eight patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELLIMM.2006.07.003

7 January 2021

Tat peptide-mediated cellular delivery: back to basics

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELLIMM.2006.07.003

7 January 2021

Long-term efficacy of enzyme replacement therapy for adenosine deaminase (ADA)-deficient severe combined immunodeficiency (SCID).

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELLIMM.2006.07.003

7 January 2021

Delivery of bioactive molecules into the cell: the Trojan horse approach

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELLIMM.2006.07.003

7 January 2021

Intracellular route and biological activity of exogenously delivered Rep proteins from the adeno-associated virus type 2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELLIMM.2006.07.003

7 January 2021

Involvement of astrocytes in purine-mediated reparative processes in the brain

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELLIMM.2006.07.003

7 January 2021

A novel TAT-mitochondrial signal sequence fusion protein is processed, stays in mitochondria, and crosses the placenta

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELLIMM.2006.07.003

7 January 2021

Ability of the Tat basic domain and VP22 to mediate cell binding, but not membrane translocation of the diphtheria toxin A-fragment

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELLIMM.2006.07.003

7 January 2021

Two novel mutations in a purine nucleoside phosphorylase (PNP)-deficient patient

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELLIMM.2006.07.003

7 January 2021

Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELLIMM.2006.07.003

7 January 2021

The role of anti-endothelial cell antibodies in Kawasaki disease - in vitro and in vivo studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELLIMM.2006.07.003

7 January 2021

Purine nucleoside phosphorylase deficiency: improved metabolic and immunologic function with erythrocyte transfusions

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELLIMM.2006.07.003

7 January 2021

The use of enzyme therapy to regulate the metabolic and phenotypic consequences of adenosine deaminase deficiency in mice. Differential impact on pulmonary and immunologic abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELLIMM.2006.07.003

7 January 2021

The C Terminus of HIV-1 Tat Modulates the Extent of CD178-mediated Apoptosis of T Cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELLIMM.2006.07.003

7 January 2021

Novel mutations and hot-spots in patients with purine nucleoside phosphorylase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELLIMM.2006.07.003

7 January 2021

A technique for ultracryotomy of cell suspensions and tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELLIMM.2006.07.003

7 January 2021

Purine nucleoside phosphorylase is associated with centrioles and basal bodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELLIMM.2006.07.003

7 January 2021

Mitochondrial basis for immune deficiency. Evidence from purine nucleoside phosphorylase-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELLIMM.2006.07.003

7 January 2021

HIV-1 Tat enters T cells using coated pits before translocating from acidified endosomes and eliciting biological responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELLIMM.2006.07.003

7 January 2021

Rituximab for congenital haemophiliacs with inhibitors: a Canadian experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELLIMM.2006.07.003

7 January 2021

In vivo protein transduction: delivery of a biologically active protein into the mouse

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELLIMM.2006.07.003

7 January 2021

Immunoglobulin replacement treatment by rapid subcutaneous infusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELLIMM.2006.07.003

7 January 2021

Protein transduction of dendritic cells for NY-ESO-1-based immunotherapy of myeloma

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELLIMM.2006.07.003

7 January 2021

Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELLIMM.2006.07.003

7 January 2021

Purine nucleoside phosphorylase deficiency associated with a dysplastic marrow morphology

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELLIMM.2006.07.003

7 January 2021